| Primary |
| Contraception |
47.1% |
| Drug Use For Unknown Indication |
22.4% |
| Product Used For Unknown Indication |
7.5% |
| Menstruation Irregular |
3.9% |
| Acne |
3.5% |
| Convulsion Prophylaxis |
1.6% |
| Drug Exposure During Pregnancy |
1.6% |
| Oral Contraception |
1.6% |
| Ovarian Cyst |
1.6% |
| Dysmenorrhoea |
1.2% |
| Pain |
1.2% |
| Ankylosing Spondylitis |
0.8% |
| Convulsion |
0.8% |
| Depression |
0.8% |
| Drug Therapy |
0.8% |
| Haemorrhage |
0.8% |
| Headache |
0.8% |
| Metrorrhagia |
0.8% |
| Multiple Sclerosis |
0.8% |
| Thyroidectomy |
0.8% |
|
| Pregnancy On Oral Contraceptive |
33.1% |
| Pulmonary Embolism |
13.2% |
| Maternal Exposure During Pregnancy |
5.0% |
| Metrorrhagia |
5.0% |
| Thrombosis |
5.0% |
| Premature Labour |
4.1% |
| Vomiting |
4.1% |
| Weight Increased |
4.1% |
| Off Label Use |
3.3% |
| Premature Baby |
3.3% |
| Therapeutic Response Unexpected With Drug Substitution |
3.3% |
| Nausea |
2.5% |
| Venous Injury |
2.5% |
| Abdominal Pain Upper |
1.7% |
| Benign Intracranial Hypertension |
1.7% |
| Drug Interaction |
1.7% |
| Hypothyroidism |
1.7% |
| Kidney Infection |
1.7% |
| Migraine |
1.7% |
| Panic Attack |
1.7% |
|
| Secondary |
| Hormone Replacement Therapy |
71.0% |
| Contraception |
11.1% |
| Product Used For Unknown Indication |
4.8% |
| Acne |
3.0% |
| B Precursor Type Acute Leukaemia |
1.5% |
| Drug Use For Unknown Indication |
1.4% |
| Post Coital Contraception |
0.9% |
| Depression |
0.7% |
| Menstruation Irregular |
0.7% |
| Blood Oestrogen Increased |
0.6% |
| Epilepsy |
0.6% |
| Pain |
0.6% |
| Progesterone Decreased |
0.6% |
| Menstrual Cycle Management |
0.4% |
| Blood Glucose Increased |
0.3% |
| Hypertension |
0.3% |
| Post Procedural Haemorrhage |
0.3% |
| Supplementation Therapy |
0.3% |
| Vulvovaginal Dryness |
0.3% |
| Back Pain |
0.2% |
|
| Breast Cancer Female |
34.7% |
| Venous Thrombosis |
12.2% |
| Pulmonary Embolism |
8.2% |
| Breast Cancer Metastatic |
4.1% |
| Deep Vein Thrombosis |
4.1% |
| Vomiting |
4.1% |
| Nausea |
3.1% |
| Vaginal Discharge |
3.1% |
| Vaginal Haemorrhage |
3.1% |
| Venous Injury |
3.1% |
| Acute Myocardial Infarction |
2.0% |
| Breast Cancer |
2.0% |
| Carcinoma In Situ |
2.0% |
| Focal Nodular Hyperplasia |
2.0% |
| Menstruation Irregular |
2.0% |
| Metrorrhagia |
2.0% |
| Off Label Use |
2.0% |
| Paralysis |
2.0% |
| Salpingectomy |
2.0% |
| Thrombosis |
2.0% |
|
| Concomitant |
| Acne |
23.8% |
| Contraception |
17.5% |
| Product Used For Unknown Indication |
10.7% |
| Drug Use For Unknown Indication |
9.8% |
| Depression |
6.0% |
| Pain |
3.7% |
| Crohn's Disease |
3.6% |
| Asthma |
3.1% |
| Premenstrual Syndrome |
3.0% |
| Anxiety |
2.8% |
| Oral Contraception |
2.6% |
| Bipolar Disorder |
1.9% |
| Post Coital Contraception |
1.7% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Headache |
1.5% |
| Nausea |
1.5% |
| Acne Cystic |
1.5% |
| Menstruation Irregular |
1.3% |
| Migraine |
1.3% |
| Multiple Sclerosis |
1.2% |
|
| Vomiting |
12.1% |
| Weight Increased |
9.7% |
| Weight Decreased |
7.5% |
| Pain |
6.3% |
| Gallbladder Disorder |
5.1% |
| Menstruation Irregular |
4.7% |
| Pulmonary Embolism |
4.7% |
| Pregnancy |
4.5% |
| Suicidal Ideation |
4.5% |
| Ventricular Extrasystoles |
4.5% |
| Cholecystitis Chronic |
4.3% |
| Nausea |
4.3% |
| Small Intestinal Obstruction |
3.8% |
| Visual Acuity Reduced |
3.8% |
| White Blood Cell Count Increased |
3.8% |
| Headache |
3.6% |
| Visual Disturbance |
3.4% |
| Injury |
3.2% |
| Urinary Tract Infection |
3.2% |
| Abdominal Pain |
3.0% |
|
| Interacting |
| Depression |
44.4% |
| Contraception |
33.3% |
| Fibromyalgia |
11.1% |
| Rheumatoid Arthritis |
11.1% |
|
| Drug Interaction |
66.7% |
| Weight Increased |
33.3% |
|
